Pacific Biosciences
PACB
S$1.88
Share price
-2.00%
Change (1 day)
-6.46%
Change (1 year)
Categories
Pacific Biosciences (PACB) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$0.98 Billion
According to Pacific Biosciences 's latest financial reports the company's total liabilities are S$0.98 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | S$1.02 B | -25.73% |
| 2023-12-31 | S$1.37 B | -14.53% |
| 2022-12-31 | S$1.61 B | -1.8% |
| 2021-12-31 | S$1.64 B | 1483.17% |
| 2020-12-31 | S$0.10 B | -17.24% |
| 2019-12-31 | S$0.12 B | 63.38% |
| 2018-12-31 | S$76.79 M | -0.97% |
| 2017-12-31 | S$77.54 M | 0.69% |
| 2016-12-31 | S$77.01 M | -5.42% |
| 2015-12-31 | S$81.43 M | -11.25% |
| 2014-12-31 | S$91.75 M | 8.08% |
| 2013-12-31 | S$84.89 M | 241.95% |
| 2012-12-31 | S$24.82 M | -28.61% |
| 2011-12-31 | S$34.77 M | 4.31% |
| 2010-12-31 | S$33.33 M | -91.46% |
| 2009-12-31 | S$0.39 B | 32.27% |
| 2008-12-31 | S$0.29 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | S$4.88 B | 395.87% | 🇺🇸 USA |
 NanoString Technologies NSTG | S$0.41 B | -57.71% | 🇺🇸 USA |
 General Electric GE | S$133.94 B | 13,506.56% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | S$63.42 B | 6,342.95% | 🇺🇸 USA |
 PerkinElmer
PKI | S$8.45 B | 758.65% | 🇺🇸 USA |